← Open Payments lookup

OLOLADE IKUOMOLA: Open Payments

NPI 1114457421 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,784 in 110 payments from 24 companies in 2025. Trend: 2023 $2,360 · 2024 $1,505 · 2025 $1,784

Food & beverage: $1,784
CompanyPaymentsAmount
Lilly USA, LLC18$320
Novo Nordisk Inc10$172
AstraZeneca Pharmaceuticals LP7$166
ABBVIE INC.16$145
PFIZER INC.18$141
E.R. Squibb & Sons, L.L.C.7$128
Dexcom, Inc.6$124
Boehringer Ingelheim Pharmaceuticals, Inc.5$123
Bayer Healthcare Pharmaceuticals Inc.3$78
Phathom Pharmaceuticals, Inc.3$69

Products named: MOUNJARO, JARDIANCE, VRAYLAR, ELIQUIS, Dexcom G6 Transmitter, BREZTRI, CAMZYOS, Kerendia.

Industry payments across MD — which companies pay providers there.